Azek price target lowered to $20 from $22 at RBC Capital

RBC Capital analyst Mike Dahl lowered the firm’s price target on Azek to $20 from $22 but keeps an Outperform rating on the shares after its Q4 earnings miss. The company’s "volume reset" has once again impacted its margins but he remains positive on the stock as its current valuation reflects much of the near-term headwinds while its long-term growth and margin story remains attractive, the analyst tells investors in a research note.